Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

The role of recent life events in the onset of obsessive-compulsive disorder.

Albert U, Maina G, Bogetto F, Ravizza L.

CNS Spectr. 2000 Dec;5(12):44-50.

PMID:
17545964
2.

Onset of obsessive-compulsive disorder: premorbid conditions and prodromal phase.

Maina G, Albert U, Bogetto F, Ravizza L.

CNS Spectr. 2000 Dec;5(12):31-43.

PMID:
17545963
3.

Consensus on the use of substituted benzamides in psychiatric patients.

Racagni G, Canonico PL, Ravizza L, Pani L, Amore M.

Neuropsychobiology. 2004;50(2):134-43. Review.

PMID:
15292667
4.

Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression.

Rocc P, De Leo C, Eva C, Marchiaro L, Milani AM, Musso R, Ravizza L, Zanalda E, Bogetto F.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Oct;26(6):1155-60.

PMID:
12452539
5.

A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder.

Rocca P, Fonzo V, Ravizza L, Rocca G, Scotta M, Zanalda E, Bogetto F.

J Affect Disord. 2002 Aug;70(3):313-7.

PMID:
12128243
6.

Refractory obsessive-compulsive disorder: state-of-the-art treatment.

Hollander E, Bienstock CA, Koran LM, Pallanti S, Marazziti D, Rasmussen SA, Ravizza L, Benkelfat C, Saxena S, Greenberg BD, Sasson Y, Zohar J.

J Clin Psychiatry. 2002;63 Suppl 6:20-9. Review.

7.
8.

Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer's disease.

Masera RG, Prolo P, Sartori ML, Staurenghi A, Griot G, Ravizza L, Dovio A, Chiappelli F, Angeli A.

Psychoneuroendocrinology. 2002 May;27(4):447-61.

PMID:
11911998
9.

Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial.

Sacchetti E, Cassano GB, Penati G, Pavan L, Nardini M, Casacchia M, Pancheri P, Muscettola G, Faravelli C, Aguglia E, Nivoli G, Ravizza L, Castrogiovanni P.

Int J Psychiatry Clin Pract. 2002;6(1):23-9. doi: 10.1080/136515002753489380.

PMID:
24931886
10.

Bulimia nervosa with and without obsessive-compulsive syndromes.

Albert U, Venturello S, Maina G, Ravizza L, Bogetto F.

Compr Psychiatry. 2001 Nov-Dec;42(6):456-60.

PMID:
11704935
11.

The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia.

Tardito D, Maina G, Tura GB, Bogetto F, Pioli R, Ravizza L, Racagni G, Perez J.

Eur Neuropsychopharmacol. 2001 Jun;11(3):221-5.

PMID:
11418282
12.

Lymphocyte peripheral benzodiazepine receptor mRNA decreases in obsessive-compulsive disorder.

Rocca P, Beoni AM, Eva C, Ferrero P, Maina G, Bogetto F, Ravizza L.

Eur Neuropsychopharmacol. 2000 Sep;10(5):337-40.

PMID:
10974604
13.

Suicide and depression.

Harwitz D, Ravizza L.

Emerg Med Clin North Am. 2000 May;18(2):263-71, ix. Review.

PMID:
10767883
14.

Recognition and treatment of dysthymia in elderly patients.

Bellino S, Bogetto F, Vaschetto P, Ziero S, Ravizza L.

Drugs Aging. 2000 Feb;16(2):107-21. Review.

PMID:
10755327
15.

Gender-related clinical differences in obsessive-compulsive disorder.

Bogetto F, Venturello S, Albert U, Maina G, Ravizza L.

Eur Psychiatry. 1999 Dec;14(8):434-41.

PMID:
10683629
16.

Altered cAMP-dependent protein kinase A in platelets of patients with obsessive-compulsive disorder.

Perez J, Tardito D, Ravizza L, Racagni G, Mori S, Maina G.

Am J Psychiatry. 2000 Feb;157(2):284-6.

PMID:
10671404
17.

Recent life events and obsessive-compulsive disorder (OCD): the role of pregnancy/delivery.

Maina G, Albert U, Bogetto F, Vaschetto P, Ravizza L.

Psychiatry Res. 1999 Dec 13;89(1):49-58.

PMID:
10643877
18.

Obsessive-compulsive syndromes in older adolescents.

Maina G, Albert U, Bogetto F, Ravizza L.

Acta Psychiatr Scand. 1999 Dec;100(6):447-50.

PMID:
10626923
19.

Delineating psychopathologic clusters within dysthymia: a study of 512 out-patients without major depression.

Serretti A, Jori MC, Casadei G, Ravizza L, Smeraldi E, Akiskal H.

J Affect Disord. 1999 Nov;56(1):17-25.

PMID:
10626776
21.

Peripheral benzodiazepine receptor messenger RNA is decreased in lymphocytes of generalized anxiety disorder patients.

Rocca P, Beoni AM, Eva C, Ferrero P, Zanalda E, Ravizza L.

Biol Psychiatry. 1998 May 15;43(10):767-73.

PMID:
9606532
22.

Hypothalamic-pituitary-adrenal axis function, psychopathological traits, and natural killer (NK) cell activity in anorexia nervosa.

Staurenghi AH, Masera RG, Prolo P, Griot G, Sartori ML, Ravizza L, Angeli A.

Psychoneuroendocrinology. 1997 Nov;22(8):575-90.

PMID:
9483703
23.

Paroxetine efficacy in the treatment of generalized anxiety disorder.

Rocca P, Fonzo V, Scotta M, Zanalda E, Ravizza L.

Acta Psychiatr Scand. 1997 May;95(5):444-50.

PMID:
9197912
24.

Episodic and chronic obsessive-compulsive disorder.

Ravizza L, Maina G, Bogetto F.

Depress Anxiety. 1997;6(4):154-8.

PMID:
9559285
25.

[Description of a case of Cotard's syndrome].

Sabbatini F, Actis-Giorgio M, Madaro A, Ravizza L.

Minerva Psichiatr. 1996 Mar;37(1):35-7. Italian.

PMID:
8926855
26.

Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder (OCD).

Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G.

Psychopharmacol Bull. 1996;32(4):677-82.

PMID:
8993091
27.

Drug treatment of obsessive-compulsive disorder (OCD): long-term trial with clomipramine and selective serotonin reuptake inhibitors (SSRIs).

Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G.

Psychopharmacol Bull. 1996;32(1):167-73.

PMID:
8927668
28.

A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients.

Dierick M, Ravizza L, Realini R, Martin A.

Prog Neuropsychopharmacol Biol Psychiatry. 1996 Jan;20(1):57-71.

PMID:
8861177
29.

[Psychological and psychopathological correlates in Dupuytren's disease].

Fagiani MB, Marocco Muttini C, Rabezzana G, Ravizza L, Messina A, Macchi R.

Minerva Psichiatr. 1995 Sep;36(3):119-26. Italian.

PMID:
8583880
30.

Predictors of drug treatment response in obsessive-compulsive disorder.

Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G.

J Clin Psychiatry. 1995 Aug;56(8):368-73.

PMID:
7635854
31.

Type I and type II schizophrenia: relations between tonic electrodermal activity and clinical ratings before and after haloperidol treatment.

Maina G, Barzega G, Bellino S, Bogetto F, Ravizza L.

Psychiatry Res. 1995 Jun 29;57(1):49-56.

PMID:
7568558
32.

[Personality disorders and obsessive-compulsive disorder: critical analysis of the literature data and our studies].

Bellino S, Barzega G, Bogetto F, Maina G, Ravizza L.

Minerva Psichiatr. 1995 Mar;36(1):47-50. Italian. No abstract available.

PMID:
7643732
33.

[Effects of total laryngectomy on the quality of life: a study on certain psychological aspects].

Bussi M, Albertini D, Bogetto F, Lombardo P, Maina G, Ravizza L, Cortesina G.

Acta Otorhinolaryngol Ital. 1994 Nov-Dec;14(6):627-32. Italian.

PMID:
7740962
34.

[The general practitioner and psychiatric assistance. A study carried out in the Piedmont region].

Maina G, Bogetto F, Ferro G, Ravizza L.

Minerva Psichiatr. 1994 Mar;35(1):31-8. Italian.

PMID:
8190031
35.

Peripheral-type benzodiazepine receptors on human blood mononuclear cells are not regulated by ovarian steroids.

Ferrero P, Rocca P, Montalenti E, Benna P, Milani A, Ravizza L, Bergamasco B.

Psychoneuroendocrinology. 1994;19(1):65-78.

PMID:
9210213
36.

[Generalized anxiety disorder. Clinical and nosological remarks].

Maina G, Aimino M, Bogetto F, Ravizza L.

Minerva Psichiatr. 1993 Dec;34(4):213-7. Italian.

PMID:
8133722
37.

[Rubidium chloride in the treatment of major depression].

Torta R, Ala G, Borio R, Cicolin A, Costamagna S, Fiori L, Ravizza L.

Minerva Psichiatr. 1993 Jun;34(2):101-10. Italian.

PMID:
8412574
38.

Peripheral-type benzodiazepine receptors and diazepam binding inhibitor-like immunoreactivity distribution in human peripheral blood mononuclear cells.

Rocca P, Bellone G, Benna P, Bergamasco B, Ravizza L, Ferrero P.

Immunopharmacology. 1993 Mar-Apr;25(2):163-78.

PMID:
8388870
39.

PD 1001: a wide range of treatments and possibilities in future clinical applications.

D'Ippolito P, Cavallini C, Ravizza L.

Perit Dial Int. 1993;13 Suppl 2:S580-2. No abstract available.

PMID:
8399670
40.

Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.

Aguglia E, Casacchia M, Cassano GB, Faravelli C, Ferrari G, Giordano P, Pancheri P, Ravizza L, Trabucchi M, Bolino F, et al.

Int Clin Psychopharmacol. 1993 Fall;8(3):197-202.

PMID:
8263318
41.

An analysis of peripheral type benzodiazepine receptors on blood mononuclear cells during high dose steroid treatment of multiple sclerosis.

Ferrero P, Rocca P, Benna P, De Leo C, Montalenti E, Ravizza L, Bergamasco B.

Ital J Neurol Sci. 1992 Nov;13(8):685-91.

PMID:
1336009
42.

[Mental retardation and psychiatric pathology. Statistical investigation and follow-up].

Ravizza L, Viarengo E, Prandi P.

Minerva Psichiatr. 1992 Apr-Jun;33(2):97-108. Italian.

PMID:
1501555
43.

[Schizophrenia and multiple sclerosis].

Borio R, Dalmotto M, Duca S, Torta R, Ravizza L.

Minerva Psichiatr. 1992 Apr-Jun;33(2):147-51. Italian.

PMID:
1501552
44.

Peripheral-type benzodiazepine receptors in blood cells of anxious patients.

Rocca P, Ravizza L, Maina G, Bergamasco B, Ferrero P.

Adv Biochem Psychopharmacol. 1992;47:229-33. Review. No abstract available.

PMID:
1324575
45.

Peripheral-type benzodiazepine receptors in anxiety disorders.

Rocca P, Ferrero P, Gualerzi A, Zanalda E, Maina G, Bergamasco B, Ravizza L.

Acta Psychiatr Scand. 1991 Dec;84(6):537-44.

PMID:
1686517
46.

An analysis of lymphocyte 3H-N-methyl-scopolamine binding in neurological patients. Evidence of altered binding in Alzheimer's disease.

Ferrero P, Rocca P, Eva C, Benna P, Rebaudengo N, Ravizza L, Genazzani E, Bergamasco B.

Brain. 1991 Aug;114 ( Pt 4):1759-70.

PMID:
1884177
47.

A study of 3H-PK 11,195 binding to "peripheral-type" benzodiazepine receptors on human lymphocytes. Evidence of decreased binding in hepatic encephalopathy.

Ferrero P, Rocca P, Gualerzi A, Benna P, Enrichens F, Olivero G, Mao P, Ravizza L, Bergamasco B.

J Neurol Sci. 1991 Apr;102(2):209-19.

PMID:
1649262
48.

[Major depression and "deterioration" of intellectual function].

Fagiani MB, Massetti L, Ravizza L.

Minerva Psichiatr. 1990 Oct-Dec;31(4):167-72. Italian.

PMID:
2096264
49.

[Use of first and second generation antidepressants. A clinical study].

Bogetto F, Binda V, Maina G, Passera R, Pastore G, Torta R, Ravizza L.

Minerva Psichiatr. 1990 Apr-Jun;31(2):77-81. Italian.

PMID:
2392043
50.

[Therapeutic treatment of drug dependence during hospital recovery].

Meluzzi A, Camerone E, Ganora D, Francesetti G, Ravizza L.

Minerva Med. 1990 Mar;81(3):203-21. Italian.

PMID:
2320287

Supplemental Content

Loading ...
Support Center